Press Release

Printer Friendly Version View printer-friendly version
<< Back
POZEN CEO to Present at the Needham & Company Second Annual Biotechnology Conference

CHAPEL HILL, N.C.--(BUSINESS WIRE)--May 29, 2003--POZEN Inc. (Nasdaq: POZN) announced today that John R. Plachetka, Pharm.D., the company's chairman, president and chief executive officer, will be speaking to investors at the Needham & Company Second Annual Biotechnology Conference on Friday, June 6, at 10:00 a.m. Eastern Time.

Dr. Plachetka will provide an overview of POZEN's business.

The presentation will be webcast live and archived on POZEN's home page at www.pozen.com.

POZEN is a pharmaceutical company developing therapeutic advancements in a cost effective manner. Since its inception, POZEN has developed the largest and most advanced product pipeline in the field of migraine. Product development efforts are focused on diseases with unmet needs and where POZEN can improve efficacy, safety, and/or patient convenience. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN." For detailed company information, see POZEN's website: www.pozen.com.

CONTACT:
POZEN Inc.
Matt Czajkowski
Chief Financial Officer
919-913-1030
or
Lisa Barthelemy
Director, Investor Relations
919-913-1044


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.